All these results suggest that SOCS3 is a direct target of miR-222-3p, and exosomic miR-222-3p might enhance tumor malignancy through SOCS3 and its downstream effectors, such as the Jak2/Stat3 and Bcl-2 pathways. Here, SOCS3 is linked to neoplasm.